Clinical trial · Observational
Spanish Academy of Dermatology and Venereology (AEDV) Melanoma Registry
Registro de Melanoma de la AEDV
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this patient registry is to describe risk factors for bad prognosis of melanoma in Spain. The main questions it aims to answer are: * To describe socioeconomical individual risk factors associated with melanoma prognosis, such as gender, residence area or socioeconomic level. * To describe potentially modifiable characteristics of health care associated with prognosis, such as waiting times, type of centre that makes the diagnosis or use of teledermatology Participants data will be gathered for analysis, without any change in the way that they are being treated.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Melanoma | Melanoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- AJCC (American Joint Committee on Cancer) TNM stage (Tumor, node, metastasis)
- timeFrame
- 1 day At diagnosis
- description
- Staging based on tumor thickness and ulceration, spread to lymph nodes and spread to distant sites.
- measure
- Breslow thickness
- timeFrame
- 1 day At diagnosis
- description
- Breslow thickness is the measurement of the depth of the melanoma from the surface of your skin down through to the deepest point of the tumour.
Secondary outcomes (2)
- measure
- Time to progression
- timeFrame
- through study completion, an average of 3 years
- measure
- Survival
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * All consecutive patients with a diagnosis of invasive primary cutaneous melanoma in participating centres. Exclusion Criteria: * In-situ melanomas * non-cutaneous melanomas, * metastatic melanoma with unknown primary site.
References
Publications (0)
Data not yet available